Personalis Inc. (NASDAQ: PSNL)
$5.2400
+0.1100 ( +2.14% ) 63.1K
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Market Data
Open
$5.2400
Previous close
$5.1300
Volume
63.1K
Market cap
$338.25M
Day range
$4.9250 - $5.2900
52 week range
$0.8906 - $7.2000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
8-k | 8K-related | 11 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |